• Title of article

    Minor immunophilin binding of tacrolimus and sirolimus metabolites

  • Author/Authors

    Diane L. Davis، نويسنده , , Jayasimha N. Murthy، نويسنده , , Heather Gallant-Haidner، نويسنده , , Randall W. Yatscoff، نويسنده , , Steven J. Soldin، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2000
  • Pages
    6
  • From page
    1
  • To page
    6
  • Abstract
    Objectives: We have previously identified three minor immunophilins of molecular weights 37 kDa, 14 kDa, and 5–8 kDa capable of binding tacrolimus and sirolimus. Design and methods: When tested against pure preparations of five sirolimus metabolites, the 14 kDa protein had almost no cross-reactivity, the 37 kDa protein cross-reacted from a high of 23.2% to <10% and the 5–8 kDa protein cross-reacted from <10% to 46.4%. When the 5–8 kDa immunophilin was tested in whole blood samples to assess interference in clinical samples, the demethylated sirolimus metabolites showed about 25% less cross-reactivity while the hydroxylated metabolites reacted about the same. Results: Since MLC data on sirolimus metabolites to date indicates that their pharmacologic potencies are ≤10% of the parent, the 14 kDa immunophilin appears to be the best candidate for a sirolimus radioreceptor assay. The 5–8 kDa immunophilin is newly identified and its cross-reactivity with tacrolimus metabolites had not been assessed. Binding of the 5–8 kDa immunophilin to pure preparations of three tacrolimus metabolites showed virtually no binding of the protein to 13-O-demethyl and 31-O-demethyl tacrolimus and binding to 15-O-demethyl tacrolimus at 121% relative to parent tacrolimus. Cross-reactivity of 15-O-demethyl tacrolimus with the 5–8 kDa protein was then assessed in whole blood samples, and it bound at a level of 163%. MLC data indicates that 31-O-demethyl tacrolimus is equipotent to parent tacrolimus in immunosuppressive activity, while the 13-O-demethyl and 15-O-demethyl have negligible immunosuppressive activity. Conclusions: Therefore, the 5–8 kDa immunophilin would have limitations in a radioreceptor assay for tacrolimus. In addition, we have evidence that the 5–8 kDa immunophilin is a subunit of a 52 kDa immunophilin previously identified by our group, and the cross-reactivity of the 5–8 kDa immunophilin with these metabolites is similar to that found previously with the 52 kDa, indicating that the two proteins could be related.
  • Keywords
    Metabolite , immunophilin , sirolimus , Tacrolimus , crossreactivity , radioreceptor assay.
  • Journal title
    Clinical Biochemistry
  • Serial Year
    2000
  • Journal title
    Clinical Biochemistry
  • Record number

    481995